查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1835471

肺動脈支架市場依產品類型、適應症、材料、病患年齡層和通路分類－全球預測，2025-2032年

Lung Stents Market by Product Type, Indication, Material, Patient Age Group, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，肺動脈支架市場規模將達到 2.3523 億美元，複合年成長率為 8.32%。

關鍵市場統計數據
基準年 2024 1.2409億美元
預計年份：2025年 1.3435億美元
預測年份 2032 2.3523億美元
複合年成長率 (%) 8.32%

本文展望了臨床需求、材料創新和醫療系統獎勵將如何共同作用，重塑肺動脈支架的研發和臨床應用。

肺動脈支架可治療多種氣道疾病，從良性結構性缺陷到惡性阻塞，並且與微創介入和個人化呼吸護理的更廣泛趨勢日益契合。臨床醫生正在採用更精密的器材設計來處理複雜的支氣管解剖結構，而工程師則正在應用先進的材料科學和製造技術來改善支架的輸送性能、徑向力分佈和生物相容性。同時，支付方和醫療系統優先考慮能夠減少加護治療使用率和再入院率的治療結果，從而獎勵採用持久可靠的治療方法，以加快患者康復並提高生活品質。

因此，肺動脈支架領域正沿著多個維度發展：人口老化和適應症擴大帶來的臨床需求；包括新型合金、聚合物化學和藥物釋放型策略在內的技術創新；以及獎勵那些展現出顯著手術療效和長期安全性的器械的商業性壓力。這些因素共同作用，使得可靠的臨床證據、可重複的生產品質和上市後監測變得愈發重要。因此，相關人員必須整合跨職能觀點——從介入性肺病學和胸腔外科到監管事務和供應鏈管理——才能順利推進下一代肺動脈支架的推廣應用，最終實現其為患者帶來的潛在益處。

重新定義肺動脈支架生態系的競爭優勢和臨床預期，簡明扼要地總結技術、監管和供應鏈的關鍵轉變

隨著材料科學、手術影像技術和患者選擇方面的進步，肺動脈支架領域正在發生顯著變化，這些進步正在改變氣道植入的設計標準和臨床預期。新型材料，例如生物可吸收聚合物和鎂基支架，旨在最大限度地減少長期異物暴露，同時提供臨時結構支撐，從而激發了人們對能夠順應組織癒合軌蹟的器械的興趣。同時，內視鏡視覺化、3D氣道建模和植入系統的改進，正在增強我們治療解剖結構複雜病變的能力，並降低圍手術全期風險。

此外，監管和報銷環境也在同步演變，監管機構日益要求提供真實世界證據和強力的核准後監測，以檢驗對照試驗以外的安全性。因此，製造商正在投資於註冊登記基礎設施和數位健康整合，以持續了解治療結果。此外，近期全球範圍內的動盪使得供應鏈韌性和生產擴充性成為戰略重點，推動了本土化生產和更緊密的供應商合作。這些轉變是結構性的，而非漸進式的，它們正在重新定義那些能夠將臨床證據生成、先進材料工程和敏捷商業化策略相結合，以滿足新的醫療標準需求的企業的競爭優勢。

本文分析了2025年美國關稅改革如何改變了肺動脈支架價值鏈的採購經濟、製造地策略和商業合約。

美國於2025年生效的關稅調整對肺動脈支架供應鏈產生了連鎖反應，反映出該產業對原料投入和成品流通貿易政策的敏感度。部分進口零件關稅的提高增加了依賴全球供應商的製造商的短期到岸成本，促使採購團隊重新評估籌資策略和總到岸成本的計算方法。為此，一些製造商加快了靠近終端市場的供應商的資格認證流程，並探索能夠在保持臨床性能的同時降低貿易費用波動風險的替代投入。

此外，關稅也影響了資本部署決策，製造商需要在投資建立更多本土產能與繼續依賴海外合作夥伴之間權衡利弊。雖然這種權衡往往導致短期內產品前置作業時間延長，但也為優先考慮臨床應用時間和客戶需求應對力的本地製造夥伴關係創造了機會。臨床醫生和醫院的採購負責人透過合約週期和庫存策略間接感受到了這些變化，許多醫療系統更傾向於選擇擁有多元化製造地的供應商，以降低關稅造成的供應中斷風險。

此外，政策環境也影響了商業談判和定價動態，支付方和集團採購組織呼籲提高成本促進因素和臨床價值的透明度。隨著轉型影響波及整個生態系統，那些制定了清晰的供應連續性計劃並維持了健全品質體系的公司，獲得了更牢固的採購關係。展望未來，關稅事件凸顯了供應鏈靈活性、跨司法管轄區的監管協調以及利用臨床和實驗室數據證明材料替代合理性的重要性，從而在控制成本的同時保障患者安全。

多層次細分分析揭示了產品類型、臨床適應症、材料科學、患者人口統計特徵和分銷管道如何驅動不同的開發和商業化需求。

細分市場層面的動態變化揭示了不同的發展軌跡和臨床應用案例，這些因素持續影響產品藍圖和商業化策略。按產品類型分類，市場包括生物可吸收支架、藥物釋放型、金屬支架和聚合物支架。生物可吸收支架又分為鎂合金支架和聚乳酸（PLLA）支架，而聚合物支架則分為可生物分解支架和不可分解支架。這些產品差異會影響臨床決策，例如支架的耐久性、發炎反應以及後續干預的必要性，從而引導研發重點轉向徑向強度、可控吸收曲線以及符合人體工學的輸送系統最佳化。從器械配置到臨床應用，基於適應症的細分涵蓋了氣道阻塞、惡性腫瘤、氣管支氣管狹窄和腫瘤相關用途，其中腫瘤適應症進一步細分為良性和惡性亞型。每種適應症都面臨獨特的操作挑戰和監管證據要求，因此需要製定客製化的研究設計和差異化的上市後監測計畫。

以聚合物為基礎的材料進一步細分為聚左旋乳酸和聚碳酸酯胺甲酸乙酯兩大類，每類材料都有不同的機械性能和生物相容性。這些材料層面的權衡取捨會影響臨床醫師的偏好和生產的複雜性，進而影響滅菌方案和保存期限。患者人群的細分也需要關注。成人、老年和兒童患者對產品尺寸、柔韌性和長期安全性的要求各不相同，這會影響標籤策略和兒科臨床試驗的發展。最後，門診手術中心、診所和醫院等分銷管道的細分會影響市場策略、服務模式和培訓項目。門診機構通常優先考慮庫存精簡和快速週轉，而醫院系統則強調全方位服務支援、廣泛的臨床培訓以及與多學科氣道團隊的整合。這些細緻的細分洞察綜合起來，揭示了開發人員和商業團隊必須如何調整產品設計、臨床證據和通路策略，以滿足不同醫療機構和病患小組的細微需求。

對美洲、歐洲、中東和非洲以及亞太地區的臨床實踐、監管複雜性和採購重點進行細緻評估，將有助於制定推廣路徑。

區域動態決定了醫療器材製造商和服務供應商在臨床、監管和商業性的不同優先事項，進而影響其策略規劃。在美洲，醫療保健系統優先考慮能夠證明手術有效性和長期安全性的證據，而供應鏈的韌性和本土製造能力也日益成為採購決策的重要因素。這些因素推動了對擁有完善臨床註冊和可預測服務模式的醫療器材的需求。相反，歐洲、中東和非洲地區（EMEA）多樣化的監管和報銷環境要求製造商調整打入市場策略，他們通常需要尋求有針對性的核准和本地合作夥伴關係，以應對分散的衛生技術評估（HTA）流程和多樣化的臨床實踐模式。

亞太地區在三級醫療機構中持續快速地推廣微創呼吸治療技術，這主要得益於對微創呼吸治療的投資以及受過專業訓練的介入醫師數量的增加。在此背景下，價格敏感度和對可擴展生產解決方案的需求將影響商業化策略，而區域夥伴關係和授權協議則可能加速該技術惠及更廣泛的患者群體。在這些全部區域。

關鍵的公司層面影響因素，重點闡述了臨床證據、卓越的製造流程、智慧財產權和合作夥伴關係將如何決定肺動脈支架領域的競爭地位。

主要企業之間的競爭優勢在於透過創新、臨床證據的累積以及推動市場准入和醫保報銷的策略聯盟實現差異化。市場領導者大力投資於器械的迭代改進，並在多個司法管轄區獲得監管部門的核准，同時開展註冊研究和上市後研究以證明其產品具有相對優勢。同時，規模較小的創新企業透過開發專用支架或新型藥物洗脫平台來開闢利基市場，它們通常與大型製造商在銷售和聯合開發方面開展合作，以高效地擴大商業規模。智慧財產權組合仍然是至關重要的資產，專利策略保護著支撐臨床差異化的關鍵材料配方、支架結構和遞送機制。

同時，各公司越來越重視整合卓越的製造流程和品質體系，以滿足嚴格的上市後監管要求，並縮短醫院供應鏈的補貨週期。與契約製造建立策略聯盟，並投資於近市場生產能力，正成為能夠提供可靠前置作業時間和區域監管合規性的公司的差異化優勢。此外，整合先進影像相容性、手術規劃軟體和結果追蹤平台等數位化工具的公司，透過降低學習門檻和實現數據主導的術後隨訪，提高了臨床醫生的接受度。綜上所述，這些競爭措施表明，成功的公司將是那些能夠將可靠的臨床數據、可擴展的製造能力和增值服務相結合，以滿足不斷變化的相關人員期望的公司。

提出切實可行的策略建議，以協調產品開發、實證項目、供應鏈韌性和商業模式，從而加速臨床應用和市場准入。

為了有效掌握臨床和商業機遇，產業領導者應採取整合策略，協調產品創新、證據產生和供應鏈韌性。首先，應優先考慮將材料選擇和器械架構與明確定義的適應症和患者群體相匹配的研發路徑，以降低監管複雜性並促進臨床醫生接受。同時，應投資於早期和持續的真實世界證據項目，以補充關鍵性試驗，因為持續的洞察有助於加強醫保報銷談判並支持器械的迭代改進。此外，加強與策略供應商的關係並實現製造地多元化，可以降低關稅和物流風險，同時加快對臨床需求的反應速度。

此外，應拓展商業模式，超越產品銷售的範疇，涵蓋臨床培訓、流程支援和數位化結果工具，以降低門診和住院環境中的應用門檻。尋求在地化的夥伴關係，以應對監管和報銷環境的差異，並在必要時考慮許可和聯合開發，以加速市場拓展，從而適應當地的臨床實踐和價格敏感度。最後，應維持積極主動的監管溝通策略，預判上市後的預期，並以透明的方式應對安全訊號。透過執行這些協調一致的行動，企業領導者可以增強其對臨床醫生、支付者和採購機構的價值提案，同時為其產品組合的永續長期應用奠定基礎。

採用透明的混合方法研究途徑，結合專家訪談、文件分析和資料三角驗證，以檢驗臨床、技術和商業性發現，並找出證據缺口。

本分析所依據的研究採用了混合方法，結合了初步的定性研究和嚴謹的二手研究，以確保對臨床、技術和商業性方面有全面的了解。初步研究工作包括對介入性肺科醫生、胸腔外科醫生、器械開發人員、採購負責人和監管專家進行結構化訪談，以獲取關於手術需求、材料性能和採購標準的第一手觀點。透過查閱臨床文獻、器械註冊資訊、監管申報文件和技術評​​估報告，檢驗了從這些訪談中得出的假設，從而支持了相關人員訪談中提出的安全性和性能主題。

資料綜合分析採用多資訊來源三角驗證法，以檢驗關鍵發現並最大限度地減少單一資訊來源偏差，特別關注設備設計特徵、材料科學發展以及上市後監測趨勢。調查方法還納入了對供應鏈脆弱性和政策變化的分析，利用公開的貿易和監管記錄來闡明關稅和製造商應對措施的影響。因此，對於存在不確定性的領域，研究重點指出了需要進一步進行一手研究或縱向註冊追蹤的方面。調查方法的透明度使讀者能夠評估證據的強度，並識別需要進一步調查或進行針對性臨床研究的空白領域。

對各項結論的全面回顧表明，整合證據產生、生產韌性和協作商業模式將決定肺動脈支架未來應用的發展軌跡。

肺動脈支架領域正處於曲折點，材料創新、手術技術進步以及不斷變化的採購動態將共同影響哪些技術最終能夠獲得臨床認可。將設計改進與可衡量的患者獲益聯繫起來，需要對臨床證據、生產可靠性以及上市後結果的了解進行協同投資。此外，近期政策的變化和供應鏈壓力凸顯了多元化採購和監管靈活性在營運中的重要性。在相關人員應對這一複雜局面的過程中，那些能夠將嚴謹的臨床數據生成與適應性生產和精準的商業策略相結合的企業，將更有利於實現持續的臨床價值和組織發展。

總之，肺動脈支架的廣泛應用不僅取決於其技術性能，還取決於可證實的患者療效、穩定的供應以及與醫療保健系統支付和採購框架的契合度。製造商、臨床醫生和採購方攜手合作，共同製定循證標準、提供培訓和生命週期支持，可以加速肺動脈支架在不斷擴大的適應症和醫療環境中的安全有效應用，最終改善患者的呼吸功能和手術效率。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 藥物釋放型氣道支架在標靶肺部藥物傳遞的應用日益廣泛
  • 開發可生物分解的肺動脈支架以減少長期併發症
  • 整合先進的影像引導系統以實現支架的精準放置
  • 在複雜解剖結構中擴大使用患者特異性3D列印氣道支架
  • 抗菌塗層支架可預防植入後感染
  • 新一代生物可吸收肺動脈支架在主要市場獲得監管部門核准
  • 自膨式金屬支架的技術進步可實現最佳氣道通暢性
  • 一項評估新型生物可吸收氣道支架治療嚴重氣管狹窄的臨床試驗
  • 支架製造商和生物技術公司在材料創新方面合作
  • 兼具藥物釋放型和徑向力支撐功能的雙用途氣道支架的市場滲透率

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 肺動脈支架市場（依產品類型分類）

  • 生物可吸收支架
    • 鎂基
    • 基於PLLA的
  • 藥物釋放型支架
  • 金屬支架
  • 聚合物支架
    • 可生物分解
    • 不可分解

9. 依適應症分類的肺動脈支架市場

  • 氣道阻塞
  • 馬拉西亞
  • 支氣管狹窄
  • 瘤
    • 良性腫瘤
    • 惡性腫瘤

第10章 肺動脈支架市場（依材料分類）

  • 鎳鈦諾
  • 聚合物基
    • 聚左旋乳酸
    • 聚碳酸酯胺甲酸乙酯
  • 不銹鋼

第11章 依病患年齡層別分類的肺動脈支架市場

  • 成人
  • 老年人
  • 孩子們

第12章 肺動脈支架市場（依通路分類）

  • 門診手術中心
  • 診所
  • 醫院

第13章 肺動脈支架市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 肺動脈支架市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國肺動脈支架市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Boston Scientific Corporation
    • Medtronic plc
    • Cook Medical LLC
    • WL Gore & Associates, Inc.
    • Taewoong Medical Co., Ltd
    • Merit Medical Systems, Inc.
    • Novatech SA
    • Meril Life Sciences Pvt. Ltd
    • Stening SRL
    • BVM Medical Limited
Product Code: MRR-437A5D08AE43

The Lung Stents Market is projected to grow by USD 235.23 million at a CAGR of 8.32% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 124.09 million
Estimated Year [2025] USD 134.35 million
Forecast Year [2032] USD 235.23 million
CAGR (%) 8.32%

A forward-looking introduction that frames how clinical demand, materials innovation, and health system incentives converge to reshape lung stent development and clinical adoption

Lung stents address a spectrum of airway pathologies that range from benign structural weakness to malignant obstruction, and they increasingly intersect with broader trends in minimally invasive intervention and personalized respiratory care. Clinicians are adopting more sophisticated device designs to manage complex tracheobronchial anatomies, while engineers apply advanced materials science and manufacturing techniques to improve deliverability, radial force profiles, and biocompatibility. At the same time, payers and health systems emphasize outcomes that reduce intensive care utilization and rehospitalization, thereby creating incentives for durable, reliable interventions that shorten recovery and improve quality of life.

Consequently, the landscape for lung stents is evolving along multiple axes: clinical demand driven by aging populations and expanded indications; technical innovation encompassing novel alloys, polymer chemistries, and drug elution strategies; and commercial pressures that reward devices demonstrating clear procedural efficiencies and long-term safety. These converging factors have heightened the importance of robust clinical evidence, reproducible manufacturing quality, and post-market surveillance. As a result, stakeholders must integrate cross-functional perspectives-from interventional pulmonology and thoracic surgery to regulatory affairs and supply chain management-to navigate adoption pathways and realize the potential patient benefits of next-generation lung stents.

A concise synthesis of pivotal technological, regulatory, and supply chain shifts that are redefining competitive advantages and clinical expectations across the lung stent ecosystem

The lung stent landscape is experiencing transformative shifts as advances in materials science, procedural imaging, and patient selection converge to change both the design criteria and clinical expectations for airway implants. Newer materials such as bioresorbable polymers and magnesium-based scaffolds aim to minimize long-term foreign body exposure while providing temporary structural support, and these options have catalyzed interest in devices that align with tissue healing trajectories. Simultaneously, improvements in endoscopic visualization, three-dimensional airway modeling, and deployment systems have expanded the ability to treat anatomically complex lesions with greater precision and lower perioperative risk.

Moreover, the regulatory and reimbursement environment is evolving in parallel, with authorities increasingly demanding real-world evidence and robust post-approval monitoring to validate safety profiles outside controlled trials. As a consequence, manufacturers are investing in registry infrastructure and digital health integrations to capture outcomes continuously. In addition, supply chain resilience and manufacturing scalability have risen as strategic priorities after recent global disruptions, prompting onshoring initiatives and closer supplier partnerships. Together, these shifts are not incremental but structural: they redefine competitive advantages toward organizations that can combine clinical evidence generation, advanced materials engineering, and agile commercialization strategies to meet the new standard of care.

An analytical review of how United States tariff reforms in 2025 altered sourcing economics, manufacturing location strategy, and commercial contracting across the lung stent value chain

The United States tariff adjustments enacted in 2025 have produced cascading effects across the lung stent supply chain, reflecting the industry's sensitivity to trade policy on both raw material inputs and finished device flows. Increased tariffs on select imported components raised immediate landed costs for manufacturers reliant on global suppliers, prompting procurement teams to reassess sourcing strategies and total landed cost calculations. In response, some producers accelerated supplier qualification programs closer to end markets and explored alternative inputs that preserve clinical performance while reducing exposure to volatile trade fees.

In addition, tariffs influenced capital deployment decisions, as manufacturers weighed the economics of incremental onshore capacity investments against continued reliance on international partners. This rebalancing often extended product lead times in the near term while creating opportunities for localized manufacturing partnerships that prioritize time-to-clinic and responsiveness to customer demand. Clinicians and hospital purchasers felt these changes indirectly through contracting cycles and inventory strategies, leading many health systems to prefer suppliers with diversified manufacturing footprints that could mitigate tariff-driven supply disruptions.

Furthermore, the policy environment shaped commercial negotiations and pricing dynamics, with payers and group purchasing organizations seeking greater transparency on cost drivers and clinical value. As transitional effects rippled through the ecosystem, companies that communicated clear supply continuity plans and maintained robust quality systems experienced stronger procurement relationships. Looking ahead, the tariff episode underscored the strategic importance of supply chain flexibility, regulatory harmonization across jurisdictions, and the capacity to justify material substitutions through clinical and bench data to preserve patient safety while controlling costs.

A multilayered segmentation analysis revealing how product type, clinical indication, material science, patient demographics, and distribution channels drive distinct development and commercialization imperatives

Segment-level dynamics reveal distinct development trajectories and clinical use-cases that continue to shape product road maps and commercialization strategies. Based on product type, the market includes bioresorbable stents, drug-eluting stents, metallic stents, and polymer stents, with bioresorbable options further differentiated into magnesium-based and PLLA-based designs and polymer stents categorized into biodegradable and nondegradable variants. These product distinctions influence clinical decision-making around durability, inflammatory response, and the need for subsequent interventions, and they guide R&D priorities toward optimizing radial strength, controlled resorption profiles, and delivery system ergonomics. Transitioning from device composition to clinical application, the indication-based segmentation captures airway obstruction, malacia, tracheobronchial stenosis, and tumor-related uses, with tumor indications further divided into benign and malignant subtypes. Each indication presents unique procedural challenges and regulatory evidence expectations, prompting tailored trial designs and differentiated post-market surveillance plans.

Material choice further intersects with performance objectives, with options spanning nitinol, polymer-based constructs, and stainless steel; polymer-based materials are further subdivided into poly-L-lactic acid and polycarbonate urethane variants that each bring different mechanical and biocompatibility profiles. These material-level trade-offs factor into both clinician preference and manufacturing complexity, affecting sterilization protocols and shelf-life considerations. Patient age group segmentation also merits attention, as adults, geriatric patients, and pediatric populations demand different sizing, flexibility, and long-term safety profiles, thereby influencing labeling strategies and pediatric study commitments. Finally, distribution channel segmentation across ambulatory surgical centers, clinics, and hospitals shapes go-to-market approaches, service models, and training programs; ambulatory settings often prioritize streamlined inventory and rapid turnover, whereas hospital systems emphasize full-service support, robust clinical training, and integration with multidisciplinary airway teams. Taken together, these granular segmentation insights highlight how developers and commercial teams must align product design, clinical evidence, and channel strategy to match the nuanced needs encountered across practice settings and patient groups.

A nuanced regional assessment of clinical practices, regulatory complexity, and procurement priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape adoption pathways

Regional dynamics impose distinct clinical, regulatory, and commercial priorities that influence strategic planning for device manufacturers and service providers. In the Americas, health systems emphasize evidence demonstrating procedural efficiency and long-term safety, while supply chain resilience and domestic manufacturing increasingly shape procurement decisions; these factors drive demand for devices supported by extensive clinical registries and predictable service models. Conversely, Europe, Middle East & Africa presents a heterogeneous landscape in which varied regulatory frameworks and reimbursement environments require adaptive market entry strategies; manufacturers often pursue targeted approvals and local partnerships to address fragmented HTA processes and diverse clinical practice patterns.

The Asia-Pacific region continues to show rapid clinical adoption in tertiary centers, propelled by investments in minimally invasive respiratory care and a growing base of trained interventional clinicians. In that context, price sensitivity and the need for scalable manufacturing solutions influence commercialization strategies, and regional partnerships or licensing arrangements can accelerate access to broader patient populations. Across these geographies, transitional factors such as local clinical training programs, reimbursement pathway clarity, and supply chain localization efforts shape adoption speed. Therefore, successful regional strategies combine robust clinical evidence, regulatory acumen, and distribution models tailored to the operational rhythms and procurement priorities of each territory.

Key company-level implications emphasizing how clinical evidence, manufacturing excellence, intellectual property, and collaborative partnerships determine competitive positioning in the lung stent arena

Competitive dynamics among leading companies center on differentiation through technological innovation, clinical evidence generation, and strategic collaborations that accelerate access and reimbursement. Market leaders invest heavily in iterative device refinement, securing regulatory approvals across multiple jurisdictions while building registries and post-marketing studies to demonstrate comparative performance. At the same time, smaller innovators carve niches by developing specialized stents or novel drug-elution platforms, and they frequently partner with larger manufacturers for distribution or co-development to scale commercialization efficiently. Intellectual property portfolios remain a critical asset, with patent strategies protecting key material formulations, scaffold architectures, and delivery mechanisms that underpin clinical differentiation.

In parallel, companies are placing greater emphasis on manufacturing excellence and quality system integration to meet intensified post-market scrutiny and to shorten time-to-replenishment in hospital supply chains. Strategic alliances with contract manufacturers and investments in near-market production capability have emerged as distinguishing capabilities for firms that can offer dependable lead times and regulatory compliance across regions. Additionally, firms that integrate digital tools-such as advanced imaging compatibility, procedure planning software, and outcomes-tracking platforms-enhance clinician adoption by lowering the learning curve and enabling data-driven post-procedural follow-up. Collectively, these competitive behaviors suggest that successful companies will be those that combine robust clinical data, scalable manufacturing, and value-added service offerings to meet evolving stakeholder expectations.

Actionable strategic recommendations that align product development, evidence programs, supply chain resilience, and commercial models to accelerate clinical adoption and market access

Industry leaders should adopt an integrated strategy that synchronizes product innovation, evidence generation, and supply chain resilience to capture clinical and commercial opportunities effectively. First, prioritize development pathways that align material selection and device architecture with clearly defined indications and patient cohorts to reduce regulatory complexity and enhance clinician uptake. Simultaneously, invest in early and sustained real-world evidence programs that complement pivotal studies, as continuous outcome capture strengthens reimbursement negotiations and supports iterative device improvement. Moreover, enhancing relationships with strategic suppliers and diversifying manufacturing footprints will mitigate tariff and logistics risks while shortening response times to clinical demand.

In addition, expand commercial models beyond product sales to include clinical training, procedural support, and digital outcomes tools that lower barriers to adoption in both ambulatory and hospital settings. Pursue targeted regional partnerships to navigate heterogeneous regulatory and reimbursement landscapes, and consider licensing or co-development arrangements to accelerate market entry where local clinical practice or price sensitivity requires adaptation. Finally, maintain a proactive regulatory engagement strategy that anticipates post-market surveillance expectations and addresses safety signals transparently. By executing these coordinated actions, leaders can strengthen their value propositions for clinicians, payers, and procurement organizations while positioning their portfolios for sustainable long-term adoption.

A transparent mixed-methods research approach combining expert interviews, document analysis, and data triangulation to validate clinical, technical, and commercial findings and identify evidence gaps

The research underlying this analysis employed a mixed-methods approach combining primary qualitative engagement and rigorous secondary review to ensure comprehensive insight into clinical, technical, and commercial dimensions. Primary efforts included structured interviews with interventional pulmonologists, thoracic surgeons, device developers, procurement officers, and regulatory specialists to capture firsthand perspectives on procedural needs, material performance, and purchasing criteria. These conversations informed hypotheses that were then tested through a targeted review of clinical literature, device registries, regulatory filings, and technology assessment reports to corroborate safety and performance themes emerging from stakeholder interviews.

Data synthesis relied on triangulation across sources to validate key findings and minimize single-source bias, with particular attention to device design characteristics, material science developments, and post-market surveillance trends. The methodology also incorporated analysis of supply chain vulnerabilities and policy shifts, using public trade and regulatory records to contextualize tariff impacts and manufacturing responses. Limitations include variability in practice patterns across regions and the evolving nature of clinical evidence for novel materials; consequently, where uncertainty exists, the analysis highlights areas requiring additional primary study or extended registry follow-up. Transparency in methodology allows readers to assess the strength of evidence and to identify gaps that warrant further investigation or targeted clinical research.

A concluding synthesis emphasizing that integrated evidence generation, manufacturing resilience, and collaborative commercial models will determine the future trajectory of lung stent adoption

The lung stent field stands at an inflection point where material innovation, procedural advances, and evolving procurement dynamics collectively influence which technologies will gain traction in clinical practice. Translating design improvements into measurable patient benefit requires coordinated investments in clinical evidence, manufacturing reliability, and post-market outcome capture. Moreover, recent policy shifts and supply chain pressures have underscored the operational importance of diversified sourcing and regulatory agility. As stakeholders navigate these complexities, those who integrate rigorous clinical data generation with adaptable manufacturing and targeted commercial strategies will be best positioned to deliver sustained clinical value and organizational growth.

In conclusion, the pathway to broader adoption depends not only on technical performance but also on demonstrable patient outcomes, seamless supply continuity, and alignment with the payment and procurement frameworks that govern health systems. Manufacturers, clinicians, and purchasers who collaborate on evidence standards, training, and lifecycle support can accelerate safe and effective use of lung stents across a widening range of indications and care settings, ultimately improving patient respiratory outcomes and procedural efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of drug eluting airway stents for targeted pulmonary drug delivery
  • 5.2. Development of biodegradable lung stents to reduce long term complications
  • 5.3. Integration of advanced imaging guidance systems for precise stent placement
  • 5.4. Growing use of patient specific 3D printed airway stents in complex anatomies
  • 5.5. Emergence of anti microbial coated stents to prevent post implantation infections
  • 5.6. Regulatory approvals of next generation bioresorbable pulmonary stents in key markets
  • 5.7. Technological advances in self expanding metallic stents for optimal airway patency
  • 5.8. Clinical trials evaluating novel bioabsorbable airway stents in severe tracheal stenosis
  • 5.9. Collaborations between stent manufacturers and biotech firms for material innovation
  • 5.10. Market penetration of dual purpose airway stents combining drug elution and radial force support

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Lung Stents Market, by Product Type

  • 8.1. Bioresorbable Stents
    • 8.1.1. Magnesium-Based
    • 8.1.2. PLLA-Based
  • 8.2. Drug-Eluting Stents
  • 8.3. Metallic Stents
  • 8.4. Polymer Stents
    • 8.4.1. Biodegradable
    • 8.4.2. Nondegradable

9. Lung Stents Market, by Indication

  • 9.1. Airway Obstruction
  • 9.2. Malacia
  • 9.3. Tracheobronchial Stenosis
  • 9.4. Tumor
    • 9.4.1. Benign Tumor
    • 9.4.2. Malignant Tumor

10. Lung Stents Market, by Material

  • 10.1. Nitinol
  • 10.2. Polymer-Based
    • 10.2.1. Poly-L-Lactic Acid
    • 10.2.2. Polycarbonate Urethane
  • 10.3. Stainless Steel

11. Lung Stents Market, by Patient Age Group

  • 11.1. Adult
  • 11.2. Geriatric
  • 11.3. Pediatric

12. Lung Stents Market, by Distribution Channel

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Lung Stents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Lung Stents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Lung Stents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Boston Scientific Corporation
    • 16.3.2. Medtronic plc
    • 16.3.3. Cook Medical LLC
    • 16.3.4. W. L. Gore & Associates, Inc.
    • 16.3.5. Taewoong Medical Co., Ltd
    • 16.3.6. Merit Medical Systems, Inc.
    • 16.3.7. Novatech SA
    • 16.3.8. Meril Life Sciences Pvt. Ltd
    • 16.3.9. Stening SRL
    • 16.3.10. BVM Medical Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL LUNG STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL LUNG STENTS MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL LUNG STENTS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LUNG STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL LUNG STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL LUNG STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS LUNG STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL LUNG STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. LUNG STENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. LUNG STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. LUNG STENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LUNG STENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL LUNG STENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL LUNG STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL LUNG STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS LUNG STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS LUNG STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 307. AFRICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 308. AFRICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 309. AFRICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 310. AFRICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 311. AFRICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. AFRICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 335. GLOBAL LUNG STENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 336. GLOBAL LUNG STENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 337. ASEAN LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. ASEAN LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. ASEAN LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. ASEAN LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. ASEAN LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 342. ASEAN LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 343. ASEAN LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 344. ASEAN LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 345. ASEAN LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 346. ASEAN LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 347. ASEAN LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 348. ASEAN LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 349. ASEAN LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 350. ASEAN LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 351. ASEAN LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 352. ASEAN LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 353. ASEAN LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 354. ASEAN LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 355. ASEAN LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 356. ASEAN LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 357. GCC LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)

TABLE 358.